前往化源商城

5-氨基乙酰丙酸盐酸盐-4-13C

更新时间:2024-01-11 07:25:45

5-氨基乙酰丙酸盐酸盐-4-13C结构式
5-氨基乙酰丙酸盐酸盐-4-13C结构式
品牌特惠专场
常用名 5-氨基乙酰丙酸盐酸盐-4-13C 英文名 5-Aminolevulinic acid-4-13C hydrochloride
CAS号 129720-94-1 分子量 168.58
密度 N/A 沸点 N/A
分子式 C413CH10ClNO3 熔点 N/A
MSDS N/A 闪点 N/A

 5-氨基乙酰丙酸盐酸盐-4-13C用途


5-氨基乙酰丙酸-4-13C(盐酸盐)是13C标记的5-氨基乙酰戊酸盐酸盐[1]。5-氨基乙酰丙酸盐酸盐(5-ALA盐酸盐)是体内血红素生物合成的中间体,也是四吡咯的普遍前体[2][3]。

 5-氨基乙酰丙酸盐酸盐-4-13C名称

中文名 5-氨基乙酰丙酸盐酸盐-4-13C
英文名 5-Aminolevulinic acid-4-13C hydrochloride

 5-氨基乙酰丙酸盐酸盐-4-13C生物活性

描述 5-氨基乙酰丙酸-4-13C(盐酸盐)是13C标记的5-氨基乙酰戊酸盐酸盐[1]。5-氨基乙酰丙酸盐酸盐(5-ALA盐酸盐)是体内血红素生物合成的中间体,也是四吡咯的普遍前体[2][3]。
相关类别
体外研究 氢、碳和其他元素的稳定重同位素已被掺入药物分子中,主要作为药物开发过程中定量的示踪剂。头韵因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
参考文献

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.  

[2]. Stummer, W., et al., Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol, 2006. 7(5): p. 392-401.  

[3]. Eyupoglu, I.Y., et al., Improving the extent of malignant glioma resection by dual intraoperative visualization approach. PLoS One, 2012. 7(9): p. e44885.  

 5-氨基乙酰丙酸盐酸盐-4-13C物理化学性质

分子式 C413CH10ClNO3
分子量 168.58
品牌现货直购
推荐供应商:


查看所有供应商和价格请点击:

5-氨基乙酰丙酸盐酸盐-4-13C生产厂家

5-氨基乙酰丙酸盐酸盐-4-13C价格

相关化合物: 更多...
5-氨基乙酰丙酸盐酸盐
5451-09-2
5-氨基乙酰丙酸盐酸盐
925-45-1
5-氨基乙酰丙酸盐酸盐-D2
187237-35-0
[3-13C]-5-氨基乙酰丙酸盐酸盐
129720-95-2
5-氨基乙酰丙酸-5-¹³C盐酸盐
52065-79-9
5-氨基酮戊酸甲酯盐酸盐
79416-27-6
5-氨基乙酰丙酸
106-60-5
4-[2-(二乙基氨基)乙基氨甲酰基]苯硼酸盐酸盐
913835-46-8
4-N,N-二甲基乙二氨酰基苯硼酸
850568-22-8
(2S,3S,4S,5R,6S)-6-[4-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-sulfamoyl-phenoxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
176223-39-5
2-[7-(2,2-dimethylpropanoylamino)-1-(7-hydroxyoctyl)-4,6-dimethyl-indol-5-yl]acetic acid
1021494-33-6
(2Z,4E,6E,8E)-9-[3-(hydroxymethyl)-4-methoxy-2,6-dimethyl-phenyl]-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
121785-73-7
(4S)-6-chloro-4-cyclopropyl-4-[2-(5-hydroxy-2-pyridyl)ethynyl]-1,3-dihydroquinazolin-2-one
167165-91-5
N-[2,3-dihydroxy-5-(2-phenylacetyl)phenyl]acetamide
473790-03-3
(2S,3S,4S,5R,6S)-6-[1-[2-(dimethylamino)ethylcarbamoyl]-5,6-dimethyl-pyrido[4,3-b]carbazol-9-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
797798-16-4
[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(2,3-dihydroxypropylamino)-13,14-dihydroxy-8-methoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
929689-90-7
(2S,3S,4S,5R,6R)-6-[[5-[5-chloro-3-(4-methylsulfonylphenyl)-2-pyridyl]-2-pyridyl]methoxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
349536-40-9
(2S,3S,4S,5R,6R)-6-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxy-quinazolin-4-yl]amino]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
944943-73-1
(2S,3S,4S,5R,6S)-6-[3-ethoxy-4-[2-[[(1R)-2-(4-methoxy-3-sulfamoyl-phenyl)-1-methyl-ethyl]amino]ethoxy]phenoxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
176223-35-1